Oshkosh, WI (June 15, 2011) - ImproMed, LLC, a Butler Schein Company and a leading developer of business and medical management software for the veterinary industry, announced today that it continues to support multiple state drug monitoring programs, including California’s Controlled Substance Utilization Review and Evaluation System, (CURES), by providing leading edge veterinary practice management software for prescription reporting.
Prescription Drug Monitoring Programs (PDMP’s) such as CURES are committed to assisting in the reduction of pharmaceutical drug diversion without affecting legitimate medical practice or patient care. Through reporting of prescription information to CURES by veterinary professionals, state law enforcement and regulatory boards are able to identify abnormal activity and stop the abuse of prescription drugs, including those used in the veterinary field.
Mandatory reporting of veterinary prescription information can be handled seamlessly through ImproMed’s Infinity Practice Management Software. Through the use of Infinity’s Inventory Module, the user is allowed to generate a detailed controlled substance report.
According to William R. Randolph, ImproMed’s Vice-President of Technical Services, “Prescription reporting can be confusing and take up valuable time. Infinity simplifies the process by allowing the practice to quickly and easily create a report that conforms to their state’s reporting regulations.”
ImproMed, a subsidiary of Butler Schein Animal Health, is a leading developer and provider of business and medical management software for the veterinary industry. ImproMed’s initial product, Infinity, has brought veterinary practice management to an entirely new level with industry-leading innovations and advancements. ImproMed’s commitment to improving the veterinary business management industry began in 1979 with the introduction of the first practice management system. Since then ImproMed has enhanced knowledge management by offering the leading advancements in technology, interfaces with more companies, and software solutions for today's veterinarian.
About Butler Schein Animal Health
Butler Schein Animal Health, the U.S. veterinary division of Henry Schein, Inc. (NASDAQ: HSIC), is the leading companion animal health distribution company in the United States. Headquartered in Dublin, Ohio, Butler Schein Animal Health employs approximately 900 Team Members, including 300 field sales representatives and 200 telesales and customer support representatives. With 17 strategically positioned, state-of-the-art distribution facilities and 12 inside sales centers nationwide, Butler Schein Animal Health maintains an order-to-fill ratio in excess of 98 percent.
Partnering with more than 400 leading animal health manufacturers worldwide, Butler Schein Animal Health is positioned to bring the broadest selection of veterinary products, strategic solutions, and technology software to more than 26,000 veterinary professionals nationwide, including: a comprehensive product offering for companion animal, equine and large animal practices; quality private-label products at an affordable value; an extensive line of capital equipment and supply products; as well as biologics, diagnostics, nutritionals, parasiticides and pharmaceuticals. For more information, visit www.butlerschein.com.